GSK plc

About GSK plc

GSK is a focused biopharma company with the ambition to unite science, technology, and talent to get ahead of disease together. Their goal is to positively impact the health of 2.5 billion people by the end of the decade, while fostering a successful, growing environment where people can thrive.

Products & Services

Product Areas:GSK offers a range of products across various therapeutic categories, detailed in specific product areas.

Products A-Z:A comprehensive list of GSK's products from A to Z, covering their portfolio of medicines and treatments.

Specialties

Respiratory, Immunology and Inflammation Oncology HIV Infectious Diseases Research and Development Clinical Trials Global Health and Health Security

Funding History

No funding data available

This company may be bootstrapped or privately funded

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tony Wood

Chief Scientific Officer

S

Sabine Luik

Chief Medical Officer

LinkedIn (Pro only)

H

Hesham Ahmed Abdullah

Senior Vice President, Global Head Oncology, Research & Development

LinkedIn (Pro only)

D

Dr Tony Wood

Chief Scientific Officer

D

Dr Sabine Luik

Chief Medical Officer

D

Dr Hesham Ahmed Abdullah

Senior Vice President, Global Head Oncology, Research & Development

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

GSK plc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised